5007302025-01-012025-03-315007302025-03-315007302024-03-315007302024-04-012025-03-315007302025-01-012025-03-31in-capmkt:OtherExpenses1Member5007302024-04-012025-03-31in-capmkt:OtherExpenses1Member5007302025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15007302025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25007302025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss35007302025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss45007302024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15007302024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25007302024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss35007302024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss45007302025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares500730NOCILNAINE163A01018NOCIL LIMITEDMain BoardEquity2024-04-012025-03-312025-05-152025-04-28INRCroresQuarterlyFourth quarterSingle segmentCompany is primarily engaged in the business of manufacture of Rubber Chemicals, which in the context of Indian Accounting Standard (Ind AS) 108 on ' Operating Segments ', constitutes a single reportable segment.2025-05-1515:30:002025-05-1519:50:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31AuditedConsolidated3396900000562000003453100000169120000033000002897000002152000003600000134900000855500000319340000025970000002597000005020000016000005180000002079000000000207900000-600400000-3925000002079000000-39250000001670200000101.251.25001.251.251.The above Statement of Standalone and Consolidated Audited Financial Results for the quarter and year ended March 31 2025 Financial Results are prepared and published in accordance with Regulation 33 of the SEBI Listing Obligations & Disclosure Requirements Regulations 2015 as amended and in accordance with the Indian Accounting Standards Ind AS as prescribed under Section 133 of the Companies Act 2013 the Act read with the relevant Rules issued thereunder and other accounting principles generally accepted in India. The Financial Results have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on May 15 2025. The Financial Results have been subjected to an audit by the statutory auditors of the Company who have expressed an unmodified opinion thereon. <BR> 2.The figures for the quarters ended March 31 as reported in these Financial Results are the balancing figures between audited figures in respect of the full financial years ended March 31 and the published year to date figures up to the end of the third quarter of the relevant financial years. <BR> 3.The Company is primarily engaged in the business of manufacture of Rubber Chemicals which in the context of Indian Accounting Standard Ind AS 108 on Operating Segments constitutes a single reportable segment. <BR> 4.The Statement of Consolidated Audited Financial Results of NOCIL Limited have been prepared in accordance with Ind AS 110 Consolidated Financial Statements. The Financial results of the wholly owned subsidiary company PIL Chemicals Limited together referred to as the NOCIL Group have been consolidated with the Company. <BR> 5.The Audited Statement of Standalone and Consolidated Cash Flows has been prepared under the indirect method as set out in Ind AS 7 Statement of Cash Flows. <BR> 6.The Audited Statement of Standalone and Consolidated Balance Sheet as at March 31 2025 and Audited Statement of Standalone and Consolidated Cash Flows for the year then ended form an integral part of the Financial Results. <BR> 7.The Board of Directors have recommended a dividend of Rs. 2 per equity share of Rs. 10 each in their meeting held on May 15 2025 which is subject to approval of the Members in the ensuing Annual General Meeting. <BR> 8.Pursuant to the Finance Act 2024 the applicable Long Term Capital Gains Tax on certain capital assets sold after July 23 2024 has been amended to 14.30 percentage from 23.296 percentage or 11.65 percentage including applicable surcharge and cess. <BR> Consequently the Company has remeasured its relevant deferred tax liabilities and the resulting credit of Rs. 14.89 crores has been recognised under the head of Deferred Tax Expense in the Statement of Profit & Loss and the Other Comprehensive Income as applicable in the results for the quarter and half year ended 30 September 2024. <BR> In case of Consolidated results the impact of the same amounting to Rs 15.38 crores has been considered.2024-04-012025-03-31AuditedConsolidated1392690000032100000014247900000798440000020400000-2550000094790000017900000535800000362560000013106500000114140000001141400000284300000-17150000011280000001028600000000010286000004340000010720000001028600000010720000000167020000010159523000006.176.15006.176.15Other Expenses855500000Other Expenses36256000008511300000597900000380000003660000000012273000000010290000013302000002352000005189000001123390000028135000002434000000310190000029950000035100000088100000595860000005644000009336500000002057040000016702000001595220000017622400000017622400000000071300000713000001731000001100300000001344700000032300000114980000011821000003403000001522400000499000003100000000160330000029480000002057040000017900000-5856000003045000000-428000000014000000051000000-7610000005358000000-53000000-172000000141000001000000021240000030100000-223000000-693000000-243000000-541600000599800000000344200000025560000000000000229000001225500000000570000000000007676200000706020000000001010000020940000003300000-3695000000046800000000004050000040500000289000005022000001780000000-502100000-616000000-2500000-618500000918000000299500000Remeasurements of the defined benefit plans-16100000Income tax on remeasurements of defined ebenfit plans1100000Change in the fair value of investments in equity instruments-683200000Income- tax on change in the fair value of investments in equity instruments97800000-600400000Remeasurements of the defined benefit plans-13700000Income tax on remeasurements of defined ebenfit plans1000000Change in the fair value of investments in equity instruments79600000Income- tax on change in the fair value of investments in equity instruments-23500000434000000000-60040000043400000AuditedtrueKalyaniwalla & Mistry LLPtrue2027-07-31